ALEXA TANNER: Open Payments
NPI 1497130801 · DAMASCUS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$348 in 14 payments from 8 companies in 2025. Trend: 2023 $241 · 2024 $262 · 2025 $348
Food & beverage: $268Education: $80
| Company | Payments | Amount |
|---|---|---|
| SANOFI-AVENTIS U.S. LLC | 1 | $80 |
| GENZYME CORPORATION | 2 | $65 |
| Incyte Corporation | 2 | $51 |
| Novartis Pharmaceuticals Corporation | 2 | $43 |
| ABBVIE INC. | 2 | $41 |
| Janssen Biotech, Inc. | 1 | $25 |
| Organon LLC | 3 | $23 |
| E.R. Squibb & Sons, L.L.C. | 1 | $21 |
Products named: DUPIXENT, OPZELURA, COSENTYX, TREMFYA, SKYRIZI, Sotyktu, RINVOQ, VTAMA.
Industry payments across MD — which companies pay providers there.
